Opportunities
Search

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN)NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required);NCORP Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed).The NCORP Community Sites is a healthcare system, a consortium of healthcare systems, or a consortia of community hospitals and/or oncology practices, public hospitals, and/or health care centers that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and care delivery clinical tri...

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN);NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required);NCORP Community Sites (UG1 Clinical Trials Not Allowed); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO)NCORP Academic Community Sites are a consortium led by an academic center with a network of community hospitals and/or oncology practices, public hospitals, and/ or other healthcare centers that serve a patient population that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and....

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Establi...

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.Distinctive Features: The FY26 CTRA offers two funding levels:• Funding Level 1 to support smaller, less complex preclinical and/or clinical research.• Funding Level 2 to support larger, more complex preclinical and/or clinical research.The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories:• Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission.• Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field.Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed.

Buyer: Lietuvos kalėjimų tarnyba | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2026-09-19

Buyer: Väylävirasto | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-20

Buyer: Vlaamse Overheid | Notice type: cn-standard | Procedure: oth-single | Contract: services | Deadline: 2026-09-21

Buyer: Gemeente Midden-Groningen | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Stichting Bevolkingsonderzoek Nederland | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: COMMUNAUTE DE COMMUNES BEAUCE VAL DE LOIRE | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Gemeente Almelo | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-21

Buyer: Tranemo kommun | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-21

Buyer: VILLE DE MER | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Oulaisten kaupunki | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-21

Buyer: COFIROUTE | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-21

Buyer: Groupement d'achats Bartholdi des établissements scolaires - Alsace | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Trafikverket Myndighet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Trafikverket Myndighet | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-21

Buyer: Trafikverket Myndighet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Trafikverket Myndighet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: IN.VA. S.P.A. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-21

Buyer: Gemeente Roosendaal | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-21

Buyer: Regionale ICT-Dienst Utrecht | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Vicepresidencia del Consejo de Administración de la Entidad Pública de Saneamiento de Aguas Residuales de la Comunidad Valenciana | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21

Buyer: Gemeente Stichtse Vecht | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-21